Patents Assigned to Tegenero GmbH
  • Patent number: 6987171
    Abstract: The invention teaches human-compatible monoclonal antibodies which are specific against human CD28 and human T-lymphocytes of several to all sub-groups to activate without occupancy of an antigen receptor of the human T-lymphocytes and thus antigen-non-specifically.
    Type: Grant
    Filed: November 24, 1999
    Date of Patent: January 17, 2006
    Assignee: Tegenero GmbH
    Inventor: Thomas Hunig